|
|
|
Volumn 3, Issue 4, 2003, Pages
|
|
Targeted delivery of therapeutics by aerosol for cancer of the lung: Preface
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
DNA TOPOISOMERASE (ATP HYDROLYSING);
DOXORUBICIN;
GAMMA INTERFERON;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
GYRASE INHIBITOR;
LIPID EMULSION;
LIPOSOME;
MICROSPHERE;
PACLITAXEL;
POLYETHYLENEIMINE;
POLYMER;
PROTEIN P53;
RECOMBINANT DNA;
RECOMBINANT INTERLEUKIN 2;
SOLID LIPID NANOPARTICLE;
THROMBOSPONDIN 1;
VASCULOTROPIN;
AEROSOL;
APOPTOSIS;
ARTHRALGIA;
CANCER IMMUNOTHERAPY;
CANCER INHIBITION;
CANCER REGRESSION;
CANCER SURVIVAL;
CYTOKINE PRODUCTION;
DOSE RESPONSE;
DRUG ADMINISTRATION ROUTE;
DRUG DELIVERY SYSTEM;
DRUG DISTRIBUTION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG POTENCY;
DRUG SAFETY;
DRUG SCREENING;
EDITORIAL;
EOSINOPHIL;
FEVER;
GENE THERAPY;
HUMAN;
INTERMETHOD COMPARISON;
LUNG CANCER;
LUNG DISEASE;
LUNG METASTASIS;
LYMPHOCYTE ACTIVATION;
MACROPHAGE;
MALAISE;
MEMORY CELL;
METASTASIS INHIBITION;
NONHUMAN;
OUTCOMES RESEARCH;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
SIDE EFFECT;
|
|
EID: 0042630954
PISSN: 15680096
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (5)
|
|
References (0)
|
